MDT

97.25

+1.88%↑

VEEV

300.62

+4.11%↑

139.72

-0.04%↓

HQY

90.34

-0.32%↓

PHR.US

23.41

+5.4%↑

MDT

97.25

+1.88%↑

VEEV

300.62

+4.11%↑

139.72

-0.04%↓

HQY

90.34

-0.32%↓

PHR.US

23.41

+5.4%↑

MDT

97.25

+1.88%↑

VEEV

300.62

+4.11%↑

139.72

-0.04%↓

HQY

90.34

-0.32%↓

PHR.US

23.41

+5.4%↑

MDT

97.25

+1.88%↑

VEEV

300.62

+4.11%↑

139.72

-0.04%↓

HQY

90.34

-0.32%↓

PHR.US

23.41

+5.4%↑

MDT

97.25

+1.88%↑

VEEV

300.62

+4.11%↑

139.72

-0.04%↓

HQY

90.34

-0.32%↓

PHR.US

23.41

+5.4%↑

Home・Akcijų sąrašas・NeoGenomics Inc

NeoGenomics Inc

Atidarymo kaina

8.97 5.53

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

8.45

Max

9.07

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-19M -45M
Pardavimai	13M 181M
Pelno marža	-24.867
Darbuotojai	2,200
EBITDA	-41M -48M

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+22.36% upside

Dividendai
By Dow Jones
Kitas uždarbis	2025-11-04

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	172M 1B
Ankstesnė atidarymo kaina	3.44
Ankstesnė uždarymo kaina	8.97

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bearish Evidence

7.7 / 10.27 Palaikymas ir pasipriešinimas

NeoGenomics Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-09-30 14:35; UTC

Pagrindinės rinkos jėgos

Robo.ai Shares Rise After $300 Million Investment From Burkhan Capital

2025-09-25 16:56; UTC

Pagrindinės rinkos jėgos

PSQ Holdings Stock Slides on Plans to Launch Crypto Treasury Service

2025-09-25 16:31; UTC

Pagrindinės rinkos jėgos

SharpLink Gaming Shares Fall on Plan to Tokenize Stock

2025-09-25 08:03; UTC

Pagrindinės rinkos jėgos

Naver Surges on Talks With Cryptocurrency-Exchange Operator

2025-09-23 18:02; UTC

Pagrindinės rinkos jėgos

Super League Shares Double After $10 Million Equity Investment From Evo Fund

2025-09-23 13:09; UTC

Įsigijimai, susijungimai, perėmimai

Innovation Beverage Strikes Deal to Merge Into BlockFuel Energy

2025-09-22 17:33; UTC

Pagrindinės rinkos jėgos

AgriFORCE Growing Systems Shares Double on New Blockchain Strategy

2025-10-02 13:17; UTC

Įsigijimai, susijungimai, perėmimai

Bitcoin Depot: Acquisition Had No Material Impact on Reported 3Q Preliminary Results >BTM

2025-10-02 13:16; UTC

Įsigijimai, susijungimai, perėmimai

Bitcoin Depot: Acquisition Brings U.S. Market Share to Roughly 30% >BTM

2025-10-02 13:16; UTC

Įsigijimai, susijungimai, perėmimai

Bitcoin Depot: Acquisition Adds Over 500 Kiosks to Network >BTM

2025-10-02 13:15; UTC

Įsigijimai, susijungimai, perėmimai

Bitcoin Depot Acquires Assets of National Bitcoin ATM, Significantly Expanding U.S. Footprint

2025-10-02 07:05; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-10-02 07:05; UTC

Rinkos pokalbiai

Bitcoin Rises Following Wall Street Rally -- Market Talk

2025-10-01 23:12; UTC

Įsigijimai, susijungimai, perėmimai

Avalanche Treasury CEO is Bart Smith

2025-10-01 23:11; UTC

Įsigijimai, susijungimai, perėmimai

Avalanche Treasury Investors Include Dragonfly, VanEck, Galaxy Digital and Others

2025-10-01 23:07; UTC

Įsigijimai, susijungimai, perėmimai

Avalanche Treasury Plans to Own More Than $1B Worth of AVAX After Becoming a Public Company

2025-10-01 23:06; UTC

Įsigijimai, susijungimai, perėmimai

Avalanche Treasury Co. Has an Exclusive Relationship With Avalanche Foundation

2025-10-01 23:04; UTC

Įsigijimai, susijungimai, perėmimai

Avalanche Treasury: Transaction Includes About $460M in Treasury Assets

2025-10-01 14:01; UTC

Rinkos pokalbiai

Bitcoin Rises as Weak Jobs Data Boost Rate-Cut Bets -- Market Talk

2025-10-01 07:27; UTC

Rinkos pokalbiai

Bitcoin Edges Lower as U.S. Government Shut Down Begins -- Market Talk

2025-09-30 14:20; UTC

Pagrindinės rinkos jėgos

Robo.ai Shares Rise After $300M Investment From Burkhan Capital

2025-09-30 06:51; UTC

Rinkos pokalbiai

Bitcoin Eases as Possible U.S. Government Shutdown Looms -- Market Talk

2025-09-29 13:48; UTC

Rinkos pokalbiai

Seasonality Could Favor Bitcoin in Coming Months -- Market Talk

2025-09-29 07:40; UTC

Rinkos pokalbiai

Bitcoin Recovers But Remains at Risk of Renewed Losses -- Market Talk

2025-09-26 07:29; UTC

Rinkos pokalbiai

Bitcoin Stabilizes After Steep Falls; Focus Turns to U.S. PCE Data -- Market Talk

2025-09-25 09:16; UTC

Rinkos pokalbiai

Bitcoin Falls as Investors Await U.S. Data -- Market Talk

2025-09-24 12:50; UTC

Įsigijimai, susijungimai, perėmimai

Fitell Corp Completes Initial $10M Solana Purchase Following the First Closing Under $100M Financing Facility

2025-09-24 06:55; UTC

Rinkos pokalbiai

Bitcoin Stays Weak After Powell Remarks -- Market Talk

2025-09-23 17:47; UTC

Pagrindinės rinkos jėgos

Super League Shares Double After $10M Equity Investment From Evo Fund

2025-09-22 20:36; UTC

Įsigijimai, susijungimai, perėmimai

Scaramucci-Backed Crypto Treasury Company Launches With $550 Million Fundraising Plan -- Update

Akcijų palyginimas

Kainos pokytis

NeoGenomics Inc Prognozė

Kainos tikslas

By TipRanks

22.36% į viršų

12 mėnesių prognozė

Vidutinis 10.67 USD 22.36%

Aukščiausias 14 USD

Žemiausias 8 USD

Remiantis 11 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines NeoGenomics Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

11 ratings

Pirkti

Laikyti

Parduoti

Remiantis 11 analitikų, pateikusių NeoGenomics Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

7.7 / 10.27Palaikymas ir pasipriešinimas

Recent bearish events outweigh bullish events.

All events are bearish.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.